Top Neuromodulation Solution Companies - 2021
Nocira: Potential Game Changer in Migraine Treatment

Top 10 Neuromodulation Solution Companies - 2021

The demand for improved patient outcomes is currently leading to the development of innovative neuromodulation technologies and devices that can address the unmet needs of patients and surgeons. Many medical device companies are now developing novel technologies and tools to improve the overall quality of life of the affected patient population. In this regard, the integration of artificial intelligence (AI) is enabling neuromodulation device provider to offer a better understanding of the brain, thereby representing the future of innovation in the sector.

As the AI technology paves the way for understanding the “language” of the nervous system, it can further be used in closed-loop experiments to test neuromodulation therapy on new targets. This can accelerate the development of treatments for a number of chronic conditions and would also be a big step closer to real-world clinical applications of AI within the body. And such progress can then create a new way to investigate medical conditions, accelerate the detection of neural biomarkers, and open the door to a new generation of AI-based neural medical procedures.

Amid such trends making a wave in the neuromodulation sector, it is becoming imperative for organizations to equip themselves with the latest and most effective technologies in the market. In order to assist such companies in shoring up their capabilities, we have compiled this issue of MedTech Outlook. In this edition, we have listed the top 10 neuromodulation solution providers to highlight the ones that can help you escalate your chances of success. Equipped with innovative technological capabilities, these enlisted service providers are transforming the neuromodulation landscape at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject-matter experts and CXOs. We hope this issue of MedTech Outlook helps you build the partnership you and your organization need to foster an environment driven by robust and efficient technology.

We present to you MedTech Outlook’s “Top 10 Neuromodulation Solution Providers – 2021”.

    Top Neuromodulation Solution Companies

    NeuroStar
    NeuroStar is an FDA-cleared, non-drug, non-invasive treatment for individuals suffering from depression and helps them attain long-term remission from their symptoms
    Nocira
    Nocira is a pre-market medical device company in the clinical evaluation of an investigational migraine treatment device designed using pressure modulation techniques. Adopting a novel approach to neuromodulation, Nocira's device provides quick relief through a few puffs of air to the ear delivered via a technique called Automated Variable Pulse Insufflation™ (AVPI™). The automated, hands-free device non-invasively creates subtle pressure changes in the outer ear by harnessing the distinctive pressure-responsive neuroanatomy of the ear that connect to the neural pathways in the brain related to headache and other migraine triggers to relieve the associated symptoms within minutes
    RS Medical
    RS Medical aims to improve the quality of life for patients with the right blend of affordable, independent, specialty electrotherapy pain relief and rehabilitation treatment options. The company distinguishes itself with the RS-4i® Plus Sequential Stimulator with Intersperse®—a device that intermixes true high-frequency (5000 Hz) INF therapy for long-lasting pain relief with NMES for muscle rehabilitation within the same session. The proprietary Intersperse treatment begins with several minutes of INF therapy, which knocks down the patient’s pain via the Gate Control Theory. What’s also unique about the device is that it controls the height and width of the neuromuscular electrical stimulation wave to deliver maximal therapeutic benefit.
    NeuroMetrix
    NeuroMetrix is a commercial stage company that was founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology. The Company has three commercial products. DPNCheck® is a diagnostic device that provides rapid, point-of-care detection of peripheral neuropathies. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of focal neuropathies. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain
    NeuroPace
    Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS® System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients suffering from drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders
    Ripple Neuro
    Ripple Neuro designs and manufactures custom neuroscience research tools to meet electrophysiological acquisition, electrical stimulation, and experimental pipeline requirements
    RST Sanexas
    RST Sanexas is a recognized leader in quantum-based electric cell signaling technology for pain and circulatory management. RST Sanexas produces several models for treating acute, chronic pain, and severe neuropathic pain. RST aims to establish itself as the undisputed world leader in Quantum based electronic medical technology and treatment. The cornerstone of our business includes the highest ethical standards, the most advanced technology, a tenacious clinical research program, and a strong customer focus
    Saluda Medical
    Saluda Medical is a global neuromodulation company leading the development and commercialization of data-driven, personalized therapies for patients with chronic pain. The company’s first product, Evoke®, is a closed-loop spinal cord stimulator (SCS) system designed to treat chronic pain, a condition that affects more than 540 million people globally. SCS treats the condition by stimulating the spinal cord and altering the transmission of pain signals to the brain. Evoke is designed to optimize pain relief by measuring and recording each patient’s unique response to stimulation, and then makes millions of real-time adjustments per day to maintain a consistent level of therapy
    SpineX
    SpineX is an early stage bioelectric medtech company developing Noninvasive Neuromodulation devices that leverages cutting-edge research from the lab of Dr. V Reggie Edgerton, PhD at UCLA. At SpineX we are committed to helping individuals with unmet clinical needs. Our goal is to use. rigorously tested neuromodulation technologies to aid recovery and restoration of bladder, bowel, respiration, sexual and sensorimotor function
    Wave Neuroscience
    Wave Neuro develops technologies that empower you to understand your unique brain and overcome barriers without pharmaceuticals or invasive procedures. We combine decades of medical research with targeted methodologies to create greater access to better healthcare. Wave Neuro takes a personalized approach to BraincareTM. We serve people, not patients. We’re all about real science, real data and brain insights that can help make it easier for you to take action on your BraincareTM and reshape your future. We make BraincareTM. technologies more accessible, more understandable, more viable, and more affordable. Wave Neuro’s vision is to empowers you to understand your unique brain and become your intrinsic best self